Navigation Links
Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
Date:3/6/2009

Therapure will apply its expertise to the development of an innovative plasma protein resulting from LFB's research

Toronto, Canada and Les Ulis, France (PRWEB) March 6, 2009 -- Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Christian Béchon, President and CEO of LFB S.A. announce that a development services contract has been concluded between Therapure Biopharma Inc. and LFB Biotechnologies, a subsidiary of LFB SA, for the development of a manufacturing method for an innovative plasma therapeutic protein.

Therapure will apply its experience and knowledge in therapeutic protein development to develop a manufacturing process to enable the large scale production of this important biologic for clinical trials. The project, which is being jointly managed by research and development teams from the two companies, is expected to yield a novel treatment for a serious illness which currently has limited treatment options.

"We are pleased that LFB Biotechnologies, a major European player in the therapeutic protein field, has selected Therapure Biopharma for this important work," said Thomas Wellner. "Our development team has extensive knowledge in the area of plasma proteins purification and manufacturing methods and we have already achieved some key milestones in this project."

"We have a strong expertise in the development and manufacture of plasma-derived medicinal products and an important R&D portfolio. We have chosen to identify partners with complementary knowledge and the skills to help us to advance some of our products," said Bernard Pelletier, strategic development program director. "We have recognized the strong technical capabilities of Therapure Biopharma in this area and we are pleased with the progress of the project to date."

About Therapure Biopharma
Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. Therapure Biopharma is also a specialist in therapies derived from hemoglobin, a blood protein. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

For more information, please visit: www.therapurebio.com.

About LFB
LFB is a pharmaceutical group and the first French company in the biotech field. LFB is the fifth largest pharmaceutical company in plasma-derived medicinal products in the world, and the third largest laboratory supplying drugs to hospitals in France. LFB commercializes a wide range of 19 plasma-derived medicinal products, addressing more than 80 pathologies in three therapeutic fields: Immunology, Hemostasis, and Intensive Care. Each year, 500,000 patients are treated with LFB's products for chronic pathologies or for emergency cases. In the biotechnology field, LFB develops monoclonal antibodies and a line of therapeutic proteins through transgenic technology with GTC Therapeutics.

For more information, please visit www.lfb.fr.

Media Contact, Therapure Biopharma Inc.:
Alison Withey
+1 705-788-0080

Media Contact, LFB S.A.:
Sandrine Charrières, Corporate Communications Director
+33 169 827 280

# # #

Read the full story at http://www.prweb.com/releases/Therapure_Biopharma/LFB_Biotechnologies/prweb2192744.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
2. Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
3. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
4. China Biopharma, Inc. Issues Corporate Information Update
5. Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
6. Wound Management Technologies, Inc. Announces Negotiations to Acquire BioPharma Management Technologies, Inc.
7. Sinobiopharma Reports Highlights of Third Quarter Results for Its Operating Subsidiary, Dong Ying China
8. Keryx Biopharmaceuticals Receives Nasdaq Notification
9. Best Practice Database Provides Key Findings for Biopharma Product Launch Evaluation
10. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results
11. Keryx Biopharmaceuticals KRX-0401 (Perifosine) Data Selected for Oral Presentation at the 50th Annual Meeting of the American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
(Date:9/22/2017)... ... ... “Cursed with a Curse: The Truth about Tithing”: a ... when breaking free from this misconception. “Cursed with a Curse: The Truth about ... Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and thought-provoking ...
(Date:9/22/2017)... ... ... “Fruit of the Spirit: “Love””: a delightful adventure of two friends who ... the Spirit: “Love”” is the creation of published author, Halimah Jones, who was born ... is an avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from ... easy to do. Users can select from up to two layers of subject matter ... of a mouse all within Final Cut Pro X. , With ProSlideshow ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... ... **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of ... can get while staying in compliance with FDA rules. , The FDA has ...
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum ... at the Global GS1 Healthcare Conference 2017 in Chicago, IL on October 17-19, ... ensuring label quality and improving patient safety. , Microscan , a ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... -- Dealmed Medical Supplies, New York City,s ... drugs, vaccines, and specialty medical products and services, announced ... acquire Vantage Medical Supplies, a major distributor of medical ... York . ... practices, will operate under the Dealmed name as of ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... 7, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Morgan ... the Grand Hyatt hotel in New York.  Zimmer Biomet ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology: